Febuxostat is a non-purine xanthine oxidase inhibitor employed in the management of hyperuricemia among patients with gout. It decreases uric acid production within the body, thus averting painful attacks of gout and joint crystal deposits.
Febuxostat 40 mg Tablets are prescribed for the long-term management of gout in adults and are typically prescribed in patients with intolerance to allopurinol.
We supply this product in bulk packs for hospitals, pharmacies, tenders, and international buyers.
🔹 Key Product Information for Buyers & Distributors
- Packing Sizes: 1×10, 1×15, 10×10 tablets or as per buyer’s request
- MOQ: Flexible based on market demand
- Labeling Options: OEM / Private Label / Neutral Packaging
- Documentation Provided: COA, MSDS, Stability Data, Product Dossier, Export Documents
Supplied to domestic distributors, hospital chains, pharmacy chains, and buyers across Africa, Asia, and the Middle East.
Q1. What is Febuxostat 40 mg Tablets utilized for?
A: Febuxostat 40 mg is used to reduce uric acid levels in patients with chronic gout to prevent gout attacks and the formation of urate crystals.
Q2. What are the strengths available?
A: We have Febuxostat in strengths of 40 mg and 80 mg, with the option of customizable packaging for bulk orders.
Q3. Do you offer OEM and private labeling services?
A: Yes. We provide OEM/private label production, neutral packaging, and private branding for international buyers.
Q4. Are your products ready to export?
A: Yes, all products are being sourced from WHO-GMP/GMP/ISO-certified factories with full export documentation.
You may also be interested in Imipenem+Cilastatin Injection – a powerful option for resistant infections.
